ID: ALA3105088

Max Phase: Preclinical

Molecular Formula: C27H34O5

Molecular Weight: 438.56

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1OCc1ccccc1)[C@H]1[C@@H](C[C@H]3C)C1(C)C

Standard InChI:  InChI=1S/C27H34O5/c1-15-12-26-16(2)10-20-21(25(20,3)4)19(23(26)30)11-18(13-28)22(29)27(26,31)24(15)32-14-17-8-6-5-7-9-17/h5-9,11-12,16,19-22,24,28-29,31H,10,13-14H2,1-4H3/t16-,19+,20-,21+,22-,24+,26+,27+/m1/s1

Standard InChI Key:  BKWJKDPWUAXVGB-WSHSHGDFSA-N

Associated Targets(Human)

Protein kinase C delta 2953 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 438.56Molecular Weight (Monoisotopic): 438.2406AlogP: 3.04#Rotatable Bonds: 4
Polar Surface Area: 86.99Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.16CX Basic pKa: CX LogP: 2.66CX LogD: 2.66
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.63Np Likeness Score: 2.70

References

1. Grue-Sørensen G, Liang X, Månsson K, Vedsø P, Dahl Sørensen M, Soor A, Stahlhut M, Bertelsen M, Engell KM, Högberg T..  (2014)  Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer.,  24  (1): [PMID:24332494] [10.1016/j.bmcl.2013.11.073]

Source